Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Simulations Plus, Inc.

Market Cap 366M 321M 296M 277M 520M 34.64B 529M 3.56B 1.37B 16.99B 1.37B 1.34B 59.08B P/E 2026 *
43.4x
P/E 2027 * 40x
Enterprise Value 366M 321M 296M 277M 520M 34.64B 529M 3.56B 1.37B 16.99B 1.37B 1.34B 59.08B EV / Sales 2026 *
4.48x
EV / Sales 2027 * 4.24x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day+0.28%
1 week+10.87%
Current month+6.08%
1 month+18.09%
3 months+55.53%
6 months-6.15%
Current year-0.44%
1 week 18.1
Extreme 18.1
18.3
1 month 15.18
Extreme 15.18
18.56
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 6.74
Extreme 6.74
90.92
Manager TitleAgeSince
Chief Executive Officer 67 25/06/2018
Director of Finance/CFO 63 30/11/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 16/07/1996
Director/Board Member 58 02/12/2014
Chairman 76 16/12/2024
Date Insider Type Main position Quantity % Market Cap.
06-15Fiscal year

Executive/Senior Manager

22,050 0.1094%
06-14Fiscal year

Executive/Senior Manager

3,150 0.0156%
06-02Sell

Executive/Senior Manager

-1,000 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+10.87%+4.73%-61.37% 366M
+4.28%-1.52%-42.98%-20.12% 24.88B
-0.98%+5.09%-37.53%+158.03% 12.79B
+2.55%-3.76%-10.39%+55.44% 5.5B
+1.89%+5.06% - - 2.92B
-2.89%+13.62% - - 2.04B
-0.70%-3.95%+37.03%-45.97% 1.76B
-1.39%-5.07%-22.01% - 1.27B
+0.29%-2.82%-31.82%-60.97% 787M
-0.67%-3.63%-34.12%+232.05% 745M
Average -0.23%+1.21%-17.13%+36.73% 5.31B
Weighted average by Cap. -0.35%-1.16%-33.64%+39.44%

Financials

2026 *2027 *
Net sales 81.71M 71.8M 66.16M 61.91M 116M 7.74B 118M 795M 307M 3.8B 307M 300M 13.2B 86.2M 75.75M 69.79M 65.31M 122M 8.16B 125M 839M 324M 4.01B 324M 317M 13.93B
Net income 9.02M 7.93M 7.31M 6.84M 12.82M 855M 13.05M 87.8M 33.91M 419M 33.87M 33.14M 1.46B 9.71M 8.53M 7.86M 7.36M 13.8M 920M 14.04M 94.48M 36.49M 451M 36.45M 35.66M 1.57B
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
23/06/26 US$18.15 +0.28% 632,044
22/06/26 US$18.10 -0.77% 967,487
18/06/26 US$18.24 -0.05% 1,045,413
17/06/26 US$18.25 +0.05% 1,429,029
16/06/26 US$18.24 +11.42% 2,174,619
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.15USD
Average target price
17.25USD
Spread / Average Target
-4.96%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!